New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 31, 2014
12:18 EDTT, PRAN, NDZ, TEVA, MNTA, MYL, MUOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday in the last trading day of the first quarter of the year. The disappointing Chicago purchasing managers' report was offset by dovish comments from Fed Chief Yellen, who said the the central bank’s "extraordinary" aid will last for "some time.” ECONOMIC EVENTS: In the U.S., the Chicago PMI business barometer index came in at 55.9, versus the consensus forecast for a 59.0 reading. In Europe, the annual inflation rate across the 18-country eurozone fell for the third consecutive month, slipping to 0.5% in March, compared to analysts' consensus forecast for a milder drop to 0.6%. COMPANY NEWS: Shares of AT&T (T) advanced early in the session after the company's board of directors authorized the repurchase of up to 300M shares, or about 6% of its common shares outstanding. The company also noted it has 125M shares left under its buyback authorization that was issued in March of last year, but the stock had given up much of its early advance to be up fractionally near noon. MAJOR MOVERS: Among the notable gainers was Canada's Nordion (NDZ), which jumped 11% after the company agreed to be acquired by Sterigenics for $11.75 per share in cash shortly after Canada's government lifted its 25% limit on foreign investment in the company. Also higher following analyst commentary was Micron (MU), which rose nearly 8% amid notes in its defense from Stifel and Pacific Crest, as well as broad-based strength in technology stocks that have recently pulled back. Among the noteworthy losers were Momenta Pharmaceuticals (MNTA), which dropped 15%, and Mylan (MYL), which slipped over 1%, after the Supreme Court agreed to hear an appeal by Teva (TEVA) of a court ruling that would enable generic versions of its multiple sclerosis drug, Copaxone, to be sold in May. Also lower were shares of Prana Biotechnology (PRAN), which plunged over 70% after its clinical study of a drug being tested as a treatment of Alzheimer's Disease did not hit its primary endpoint. INDEXES: Near midday, the Dow was up 118.43, or 0.73%, to 16,441.49, the Nasdaq was up 52.48, or 1.26%, to 4,208.23, and the S&P 500 was up 14.56, or 0.78%, to 1,872.18.
News For T;PRAN;NDZ;TEVA;MNTA;MYL;MU From The Last 14 Days
Check below for free stories on T;PRAN;NDZ;TEVA;MNTA;MYL;MU the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
July 23, 2014
16:08 EDTTAT&T reports Q2 wireless revenue up 3.7% versus the year-ago quarter
Subscribe for More Information
16:04 EDTTAT&T sees FY14 EPS growth at low end of mid-single digit range, consensus $2.62
Sees FY14 consolidated revenue growth in the 5% range, consensus $133.93B. Sees FY14 free cash flow in the $11B range. Sees FY14 capital expenditures remaining in the $21B range.
16:02 EDTTAT&T reports Q2 EPS 62c, consensus 63c
Subscribe for More Information
15:30 EDTTNotable companies reporting after market close
Subscribe for More Information
15:10 EDTTAT&T jv near purchase of majority stake in Fullscreen, Re/code reports
Otter Media, the joint venture between AT&T and the Chernin Group, is near a deal to buy a majority stake in YouTube network Fullscreen that will value the company at between $200M-$300M, according to Re/code, citing sources. Reference Link
13:48 EDTTEarnings Preview: AT&T sentiment mixed ahead of Q2 report
Subscribe for More Information
10:02 EDTMYL, TEVAOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:10 EDTMYL, TEVADeutsche Bank hosts an analyst Specialty Pharma/Industry conference call
Subscribe for More Information
07:09 EDTMYLMylan wins restraining order against Apotex for generic version of GSK's Paxil
Subscribe for More Information
06:45 EDTMYLLawmakers divided on inversion deals, NY Times says
Subscribe for More Information
July 22, 2014
16:08 EDTTEVATeva initiated with a Buy at Deutsche Bank
Subscribe for More Information
16:08 EDTMYLMylan initiated with a Buy at Deutsche Bank
Target $67.
07:28 EDTTAT&T volatility elevated into Q2 and outlook
Subscribe for More Information
July 21, 2014
08:11 EDTTEVAArena Pharma' subsidiary enters into agreement for Belviq with Teva subsidiary
Subscribe for More Information
08:08 EDTTAT&T awarded $275M contract U.S. Department of State
Subscribe for More Information
08:01 EDTTEVATeva completes acquisition of Labrys
Subscribe for More Information
July 18, 2014
16:47 EDTMYLMarket ends week higher as earnings, M&A offset geopolitical tensions
Subscribe for More Information
12:51 EDTMYLKey GOP senator signals readiness for inversion deal, The Hill says
Subscribe for More Information
11:42 EDTMUAMD plummets after profit miss, analyst downgrades
Subscribe for More Information
06:02 EDTMUDRAMeXchange: Global DRAM module sales grew 32% in 2013, DigiTimes says
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use